首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1907927

脂质体市场按类型、结构、脂质组成、製剂技术、载药方法、应用、给药途径、最终用户和地区划分

Liposomes Market, By Type, By Structure, By Lipid Composition, By Technique of Preparation, By Drug Loading Method, By Application, By Route of Administration, By End User, By Geography

出版日期: 2025年12月11日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2025 年，脂质体市值将达到 53.4 亿美元，到 2032 年将达到 100.8 亿美元，2025 年至 2032 年的复合年增长率为 9.5%。

分析范围		分析详情
基准年	2024	市场规模（2025 年）	53.4亿美元
效能数据	2020-2024	预测期	2025-2032
预测期（2025-2032 年）复合年增长率	9.50%	预计金额（2032 年）	100.8亿美元

全球脂质体市场是製药和生物技术产业中一个快速发展的细分市场，其特点是利用磷脂基囊泡结构来增强治疗效果的先进药物传递系统。

脂质体作为一种生物相容性和生物可降解的载体，透过提供一种标靶药物递送机制，彻底改变了製药业。这种机制显着提高了药物的生物利用度，同时最大限度地减少了副作用。这些微小的球形囊泡由一层或多层磷脂双分子层包裹的水性核心组成，是封装亲水性和疏水性药物、蛋白质、胜肽和遗传物质的理想平台。

市场扩张的驱动因素包括慢性病盛行率的上升、对个人化医疗日益增长的需求以及对奈米技术药物递送系统的大量投资。脂质体在肿瘤学、感染疾病、眼科和疫苗研发等许多领域都有应用，展现出在多个医学领域改善治疗效果的巨大潜力。

先进製造技术的整合，加上创新脂质体配方的监管核准，使该市场成为现代药物开发策略的关键组成部分，吸引了许多成熟製药公司和寻求利用下一代药物输送解决方案的新兴生物技术公司的注意。

市场动态

全球脂质体市场受多种强劲的市场驱动因素所推动。其中最主要的驱动因素是全球癌症和慢性疾病的日益普遍，这迫切需要更有效、更具针对性的治疗性介入，而脂质体药物递送系统恰恰能够满足这一需求。此外，人口老化加剧、医疗保健支出不断增长以及人们对先进药物递送机制的认识不断提高，也显着促进了市场的扩张。

脂质体生产流程的技术进步，例如远端装载技术和隐形脂质体开发，提高了产品的稳定性和治疗效果，促使製药公司对脂质体製剂进行大量投资。然而，市场也面临着许多限制因素，包括脂质体产品高昂的研发和生产成本、复杂的监管核准流程导致产品上市时间延长，以及在维持产品品质和均一性的同时扩大生产规模所面临的技术挑战。

其他挑战包括现有脂质体製剂的专利到期以及其他药物递送系统的激烈竞争。儘管有这些限制，脂质体在基因治疗、疫苗研发和个人化医疗领域日益广泛的应用也带来了巨大的机会。

对罕见疾病治疗日益增长的关注、新兴市场对脂质体製剂的日益普及，以及其在化妆品和营养保健品领域的潜在应用，都预示着脂质体药物递送系统盈利的成长潜力。製药公司与研究机构之间的策略合作，以及政府对奈米技术研究的支持，都为脂质体药物递送系统的市场扩张和创新创造了有利环境。

本报告的主要特点

本报告对全球脂质体市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
全球脂质体市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
《全球脂质体市场》报告面向该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球脂质体市场的各种策略矩阵更轻鬆地做出决策。

北美洲
- 美国
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第十三章竞争格局

Gilead Sciences
Johnson and Johnson
Sun Pharmaceutical Industries
Pacira BioSciences
Luye Pharma Group
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries
Novartis
Ipsen
Bristol Myers Squibb
Pfizer
Merck
Evonik Health Care
Fujifilm
Polymun Scientific

第十四章分析师建议

机会
分析师观点
Coherent Opportunity Map (COM)

第十五章参考文献与分析方法

参考
分析方法
关于 Coherent Market Insights

简介目录

Product Code: CMI9056

Liposomes Market is estimated to be valued at USD 5.34 Bn in 2025 and is expected to reach USD 10.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.34 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.50%	2032 Value Projection:	USD 10.08 Bn

The global liposomes market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, characterized by sophisticated drug delivery systems that leverage phospholipid-based vesicular structures to enhance therapeutic efficacy.

Liposomes, as biocompatible and biodegradable carriers, have revolutionized the pharmaceutical landscape by offering targeted drug delivery mechanisms that significantly improve bioavailability while minimizing adverse effects. These microscopic spherical vesicles, composed of one or more phospholipid bilayers surrounding an aqueous core, serve as versatile platforms for encapsulating both hydrophilic and lipophilic drugs, proteins, peptides, and genetic materials.

The market's expansion is driven by increasing prevalence of chronic diseases, growing demand for personalized medicine, and substantial investments in nanotechnology-based drug delivery systems. With applications spanning oncology, infectious diseases, ophthalmology, and vaccine development, liposomes have demonstrated remarkable potential in enhancing therapeutic outcomes across diverse medical fields.

The integration of advanced manufacturing technologies, coupled with regulatory approvals for innovative liposomal formulations, has positioned this market as a critical component of modern pharmaceutical development strategies, attracting significant attention from both established pharmaceutical companies and emerging biotechnology firms seeking to capitalize on next-generation drug delivery solutions.

Market Dynamics

The global liposomes market is propelled by several compelling drivers, primarily the escalating prevalence of cancer and chronic diseases worldwide, which necessitates more effective and targeted therapeutic interventions that liposomal drug delivery systems uniquely provide. The growing geriatric population, coupled with increasing healthcare expenditure and rising awareness about advanced drug delivery mechanisms, significantly contributes to market expansion.

Technological advancements in liposome manufacturing processes, including remote loading techniques and stealth liposome development, have enhanced product stability and therapeutic efficacy, driving pharmaceutical companies to invest heavily in liposomal formulations. However, the market faces notable restraints including high development and manufacturing costs associated with liposomal products, complex regulatory approval processes that extend time-to-market, and technical challenges related to scale-up production while maintaining product quality and consistency.

Patent expirations of established liposomal drugs and intense competition from alternative drug delivery systems pose additional challenges. Despite these constraints, significant opportunities emerge from the expanding applications of liposomes in gene therapy, vaccine development, and personalized medicine sectors.

The growing focus on rare disease treatments, increasing adoption of liposomal formulations in emerging markets, and potential applications in cosmetics and nutraceuticals present lucrative growth avenues. Strategic collaborations between pharmaceutical companies and research institutions, along with government initiatives supporting nanotechnology research, create favorable conditions for market expansion and innovation in liposomal drug delivery systems.

Key Features of the Study

This report provides in-depth analysis of the global liposomes market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global liposomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Gilead Sciences, Johnson and Johnson, Sun Pharmaceutical Industries, Pacira BioSciences, Luye Pharma Group, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Novartis, Ipsen, Bristol Myers Squibb, Pfizer, Merck, Evonik Health Care, Fujifilm, and Polymun Scientific
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global liposomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposomes market

Market Segmentation

Type Insights (Revenue, USD Bn, 2020 - 2032)
- Conventional Liposomes
- PEGylated Liposomes
- Ligand-Targeted Liposomes
- Long-Circulating (Stealth) Liposomes
- pH-Sensitive Liposomes
- Temperature-Sensitive Liposomes
- Cationic Liposomes
Structure Insights (Revenue, USD Bn, 2020 - 2032)
- Multilamellar Vesicles
- Small Unilamellar Vesicles
- Large Unilamellar Vesicles
- Giant Unilamellar Vesicles
Lipid Composition Insights (Revenue, USD Bn, 2020 - 2032)
- Phospholipid-Based Liposomes
- Cholesterol-Enriched Liposomes
- Sphingomyelin-Based Liposomes
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Natural Lipid Liposomes
Technique of Preparation Insights (Revenue, USD Bn, 2020 - 2032)
- Thin Film Hydration
- Reverse-Phase Evaporation
- Ethanol Injection
- Microfluidics-Based Production
- Detergent Removal
- Freeze-Thaw Method
- High-Pressure Homogenization
Drug Loading Method Insights (Revenue, USD Bn, 2020 - 2032)
- Passive Loading
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Delivery
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Dermatology
- Gene Delivery
- Vaccine Delivery
- Cosmetics and Personal Care
- Nutraceuticals
- Diagnostics and Imaging
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous
- Intramuscular
- Subcutaneous
- Oral
- Topical
- Inhalation
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinics
- Cosmetics and Personal Care Manufacturers
- Contract Research and Manufacturing Organizations (CROs/CMOs)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Gilead Sciences
- Johnson and Johnson
- Sun Pharmaceutical Industries
- Pacira BioSciences
- Luye Pharma Group
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries
- Novartis
- Ipsen
- Bristol Myers Squibb
- Pfizer
- Merck
- Evonik Health Care
- Fujifilm
- Polymun Scientific

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Liposomes Market, By Type
- Global Liposomes Market, By Structure
- Global Liposomes Market, By Lipid Composition
- Global Liposomes Market, By Technique of Preparation
- Global Liposomes Market, By Drug Loading Method
- Global Liposomes Market, By Application
- Global Liposomes Market, By Route of Administration
- Global Liposomes Market, By End User
- Global Liposomes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Liposomes Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Conventional Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
PEGylated Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ligand-Targeted Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Long-Circulating (Stealth) Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
pH-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Temperature-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cationic Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Liposomes Market, By Structure, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Multilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Small Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Giant Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Liposomes Market, By Lipid Composition, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Phospholipid-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cholesterol-Enriched Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sphingomyelin-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Natural Lipid Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Liposomes Market, By Technique of Preparation, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Thin Film Hydration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Reverse-Phase Evaporation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ethanol Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microfluidics-Based Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Detergent Removal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Freeze-Thaw Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
High-Pressure Homogenization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Liposomes Market, By Drug Loading Method, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Passive Loading
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Liposomes Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Vaccine Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cosmetics and Personal Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostics and Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Liposomes Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Liposomes Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cosmetics and Personal Care Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research and Manufacturing Organizations (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Liposomes Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

13. Competitive Landscape

Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacira BioSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Luye Pharma Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ipsen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evonik Health Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fujifilm
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Polymun Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

14. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

15. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

脂质体市场按类型、结构、脂质组成、製剂技术、载药方法、应用、给药途径、最终用户和地区划分

Liposomes Market, By Type, By Structure, By Lipid Composition, By Technique of Preparation, By Drug Loading Method, By Application, By Route of Administration, By End User, By Geography

市场动态

目录

第一章分析目标和先决条件

第二章市场展望

第三章：市场动态、监管与趋势分析

第四章全球脂质体市场（按类型划分）（2020-2032 年）

5. 全球脂质体市场依结构划分（2020-2032 年）

6. 全球脂质体市场依脂质组成划分（2020-2032 年）

7. 全球脂质体市场依製剂技术划分（2020-2032 年）

8. 全球脂质体市场依载药方法划分（2020-2032 年）

9. 全球脂质体市场按应用领域划分（2020-2032 年）

10. 全球脂质体市场依给药途径划分（2020-2032 年）

第十一章全球脂质体市场（以最终用户划分）（2020-2032 年）

第十二章全球脂质体市场（按地区划分）（2020-2032 年）